NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

MannKind Corporation (NASDAQ: MNKD)

 
MNKD Technical Analysis
1
As on 2nd Dec 2021 MNKD Share Price closed @ 4.42 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MNKD Share Price

Open 4.42 Change Price %
High 4.51 1 Day N/A N/A
Low 4.27 1 Week 0.00 0.00
Close 4.42 1 Month 0.00 0.00
Volume 2268393 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
NASDAQ USA Most Active Stocks
ARDX 1.70 %
AAPL 163.76 %
SNDL 0.59 %
PHUN 3.50 %
CFVI 10.58 %
LCID 48.41 %
ABUS 4.31 %
FAMI 0.24 %
AAL 17.42 %
AMD 150.68 %
 
NASDAQ USA Top Gainers Stocks
BOWXW 2.97 29.13%
KURI 10.90 18.48%
BOWXU 11.18 15.62%
HJLIW 0.56 14.29%
LSAQ 10.05 11.54%
MITAW 0.85 10.39%
MRAC 10.92 10.08%
DEH-WT 1.72 8.86%
STWOU 8.48 8.16%
AMHCU 16.28 7.81%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
SGAMU 10.45 -27.93%
NOVVR 0.40 -25.93%
SGAM 9.62 -24.84%
CAHC 7.94 -20.12%
BCYP 8.44 -19.23%
SGAMW 1.25 -13.19%
GLEO-UN 9.80 -12.19%
 
 
MNKD
Daily Charts
MNKD
Intraday Charts
Whats New @
Bazaartrend
MNKD
Free Analysis
 
MNKD Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
MNKD Target for Month December
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
MNKD Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
MNKD Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
MNKD Other Details
Segment EQ
Market Capital 1187133312.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MNKD Address
MNKD
 
MNKD Latest News
 
Your Comments and Response on MannKind Corporation
 
MNKD Business Profile
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity used for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of Treprostinil (Tyvaso DPI) used for the treatment of pulmonary arterial hypertension; and Thirona Bio to evaluate the therapeutic potential of TGF-ß inhibitor for the treatment of pulmonary fibrosis. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. Address: 30930 Russell Ranch Road, Westlake Village, CA, United States, 91362
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service